Page results
-
This page describes a surgical keyhole procedure to remove fibroids, called a laparoscopic myomectomy.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
EMIS outage caused backlog of result messages via Keystone
-
This page provides information about the Palliative care and symptom control team
-
Contact details of clinical lead adults and lead paediatrics
-
This patient information explains an inguinal gonadectomy.
-
This patient information explains laparoscopic gonadectomy.
-
Information about hyperthermic intraperitoneal chemotherapy (HIPEC), including about the risks and benefits, and alternatives to the treatment.
File results
-
FOI/2022/0026 - Patients referred for puberty blockers/ services related to gender identity
-
FOI/2022/0029 - Treatment and charges for overseas visitors and migrants
-
FOI/2022/0040 - Agency spend for doctors, nurses and allied health professionals
-
FOI/2022/0048 - Cancer deaths in relation to Covid-19
-
FOI/2022/0069 - Trust’s flexible endoscope inventory
-
FOI/2022/0094 - Emergency Covid funding - private FM contractors
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0118 - Contact centre/ Call centre contracts
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0161 - Referral to treatment waiting times